Lemonade, Inc.
LMND NYSE Fire, Marine & Casualty Insurance Financials FY2018βFY2025
What Lemonade, Inc. does
No business description yet.
- Legal name
- Lemonade, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001691421-26-000016
0001691421
Revenue and margins
Lemonade, Inc. had $738M of revenue in fiscal 2025, up 40.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$25.9M in fiscal 2025, β3.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Lemonade, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 4.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Lemonade, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $381M | $382M | $310M | $404M | $399M |
| Total assets | $1.5B | $1.7B | $1.6B | $1.8B | $1.9B |
| Total liabilities | $522M | $824M | $924M | $1.3B | $1.4B |
| Shareholders' equity | $988M | $867M | $709M | $593M | $534M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β | β7.3% | β4.9% | β8.3% | β8.4% | β7.1% | β11.0% | β7.9% |
| Altman Z'' | β | β | β | β | β | β | β | β |
8 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $22.5M | $67.3M | $94.4M | $128M | $257M | $430M | $527M | $738M |
| Research and development | $4.7M | $9.8M | $19.4M | $51.8M | $79.6M | $88.8M | $85.8M | $93.9M |
| Pretax income | β$52.6M | β$108M | β$121M | β$234M | β$295M | β$230M | β$204M | β$161M |
| Income tax | $0.3M | $0.6M | $1.5M | $7.7M | $3.0M | $7.1M | β$1.7M | $4.6M |
| Net income | β$52.9M | β$109M | β$122M | β$241M | β$298M | β$237M | β$202M | β$166M |
| Net income to common | β$52.9M | β$109M | β$122M | β$241M | β$298M | β$237M | β$202M | β$166M |
| Diluted EPS | β$4.84 | β$9.75 | β$3.63 | β$3.94 | β$4.59 | β$3.40 | β$2.85 | β$2.24 |
| Diluted shares | 0.01B | 0.01B | 0.03B | 0.06B | 0.06B | 0.07B | 0.07B | 0.07B |
| Cash flow | ||||||||
| Cash from operations | β$40.8M | β$78.1M | β$91.7M | β$145M | β$163M | β$119M | β$11.4M | β$16.5M |
| Capital expenditure | $0.7M | $2.7M | $4.4M | $9.4M | $10.1M | $9.2M | $9.4M | $9.4M |
| Free cash flow | β$41.5M | β$80.8M | β$96.1M | β$154M | β$173M | β$128M | β$20.8M | β$25.9M |
| Depreciation and amortization | $0.1M | $0.6M | $1.7M | $3.7M | $12.2M | $20.0M | $20.0M | $15.2M |
| Stock-based compensation | $2.1M | $4.3M | $10.6M | $44.1M | $59.3M | $59.9M | $64.5M | $61.3M |
| Acquisitions | β | β | $0.0M | $0.0M | β$98.8M | $0.0M | $0.0M | β |
| Balance sheet | ||||||||
| Cash and short-term investments | $102M | $325M | $571M | $381M | $382M | $310M | $404M | $399M |
| Property and equipment, net | β | $3.1M | $5.7M | $11.7M | $19.6M | $17.4M | $16.1M | $15.8M |
| Goodwill | β | β | β | $0.0M | $19.0M | $19.0M | $19.0M | $19.0M |
| Intangible assets | β | β | β | $0.6M | $32.5M | $22.9M | $13.6M | $8.1M |
| Total assets | β | $414M | $829M | $1.5B | $1.7B | $1.6B | $1.8B | $1.9B |
| Total liabilities | β | $117M | $288M | $522M | $824M | $924M | $1.3B | $1.4B |
| Shareholders' equity | β$79.1M | β$183M | $541M | $988M | $867M | $709M | $593M | $534M |
| Margins | ||||||||
| Net margin | β235.1% | β161.2% | β129.6% | β187.9% | β116.0% | β55.1% | β38.4% | β22.4% |
| FCF margin | β184.4% | β120.1% | β101.8% | β119.9% | β67.4% | β29.9% | β4.0% | β3.5% |
| Returns | ||||||||
| Return on equity | β | β | β68.2% | β31.6% | β32.1% | β30.1% | β31.1% | β29.4% |
| Return on assets | β | β26.2% | β19.7% | β20.6% | β18.6% | β14.3% | β11.6% | β8.8% |
| Return on tangible equity | β | β | β22.6% | β24.4% | β36.5% | β35.5% | β36.1% | β32.7% |
| Growth | ||||||||
| Revenue growth | β | 199.1% | 40.3% | 36.0% | 99.9% | 67.4% | 22.5% | 40.2% |
| Share count change | β | 1.8% | 202.5% | 81.9% | 6.0% | 7.3% | 2.0% | 4.1% |
| Capital allocation | ||||||||
| Capex / revenue | 3.1% | 4.0% | 4.7% | 7.3% | 3.9% | 2.1% | 1.8% | 1.3% |
| Stock comp / revenue | 9.3% | 6.4% | 11.2% | 34.3% | 23.1% | 13.9% | 12.3% | 8.3% |
| Quality scores | ||||||||
| Accruals ratio | β | β7.3% | β4.9% | β8.3% | β8.4% | β7.1% | β11.0% | β7.9% |
Source: SEC EDGAR XBRL filings (CIK 0001691421). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.